Bio-Rad Laboratories Price to Free Cash Flow Ratio 2010-2022 | BIO.B

Historical price to free cash flow ratio values for Bio-Rad Laboratories (BIO.B) since 2010. For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Bio-Rad Laboratories Price to Free Cash Flow Ratio Historical Data
Date Stock Price TTM FCF per Share Price to FCF Ratio
2023-01-26 404.66 0.00
2022-09-30 418.65 $-6.23 0.00
2022-06-30 471.62 $-1.32 0.00
2021-12-31 722.91 $17.74 40.76
2021-09-30 759.91 $22.06 34.44
2021-06-30 640.00 $19.44 32.93
2021-03-31 579.38 $17.55 33.02
2020-12-31 574.15 $15.80 36.34
2020-09-30 508.00 $12.16 41.78
2020-06-30 436.97 $10.68 40.90
2020-03-31 351.32 $12.63 27.81
2019-12-31 369.60 $11.91 31.03
2019-09-30 340.54 $9.12 37.35
2019-06-30 306.18 $8.09 37.85
2019-03-31 303.00 $5.50 55.09
2018-12-31 230.00 $5.29 43.46
2018-09-30 297.67 $5.03 59.15
2018-06-30 285.75 $3.98 71.78
2018-03-31 250.90 $3.39 73.93
2017-12-31 238.25 $-0.24 0.00
2017-09-30 228.01 $0.27 838.89
2017-06-30 225.00 $0.58 390.02
2017-03-31 199.80 $-0.24 0.00
2016-12-31 183.15 $4.50 40.74
2022-03-31 587.56 $1.44 408.94
2016-09-30 162.52 $1.13 143.89
2016-06-30 141.99 $2.66 53.31
2016-03-31 135.03 $1.34 101.11
2015-12-31 137.68 $2.53 54.50
2015-09-30 132.79 $2.25 59.00
2015-06-30 146.50 $2.46 59.44
2015-03-31 135.00 $3.83 35.22
2014-12-31 120.51 $5.24 23.02
2014-09-30 115.55 $6.71 17.22
2014-06-30 123.45 $5.75 21.48
2014-03-31 127.95 $4.04 31.70
2013-12-31 123.71 $2.20 56.15
2013-09-30 118.00 $2.89 40.84
2013-06-30 113.00 $2.90 39.03
2013-03-31 122.25 $4.17 29.34
2012-12-31 104.08 $4.54 22.94
2012-09-30 108.61 $3.99 27.23
2012-06-30 100.33 $3.71 27.03
2012-03-31 103.42 $0.72 143.78
2011-12-31 95.31 $3.14 30.35
2011-09-30 90.10 $3.19 28.23
2011-06-30 117.87 $2.86 41.26
2010-12-31 104.57 $4.93 21.23
2010-09-30 91.05 $11.69 7.79
2010-06-30 87.25 $10.10 8.64
2010-03-31 103.14 $12.43 8.30
2009-12-31 97.86 $15.48 6.32
2011-03-31 118.57 $5.83 20.35
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $12.069B $2.923B
BIO-RAD LABORATORIES, INC. manufactures and supplies to life sciences research, healthcare, analytical chemistry, semiconductor and other markets a broad range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $155.571B 9.49
GSK (GSK) United Kingdom $71.996B 8.97
QIAGEN (QGEN) Netherlands $11.433B 19.52
Ginkgo Bioworks Holdings (DNA) United States $3.414B 0.00
Myovant Sciences (MYOV) United Kingdom $2.604B 0.00
Arcus Biosciences (RCUS) United States $1.676B 25.16
Biohaven (BHVN) United States $1.305B 0.00
Emergent Biosolutions (EBS) United States $0.671B 5.28
ADC Therapeutics SA (ADCT) Switzerland $0.359B 0.00
Ambrx Biopharma (AMAM) United States $0.083B 0.00
Enzo Biochem (ENZ) United States $0.073B 0.00
Gelesis Holdings (GLS) United States $0.028B 0.00
SQZ Biotechnologies (SQZ) United States $0.024B 0.00